News & Announcements

A recent Northwestern Medicine study may improve the understanding of mitochondrial dysfunction and its impact on the development of neurological diseases.

A Northwestern Medicine scientist and collaborators have used an AI-enhanced precision medicine approach to combine multiple views of human brain development as they seek to provide a roadmap for what causes subtypes of autism spectrum disorder.

Northwestern Medicine investigators have discovered that a specific protein known for its role in cell division also impacts the direction of intracellular transport in neurons.

African Americans who were exposed to segregation in their neighborhoods during young adulthood are more likely to have poor cognitive performance as early as midlife.

Both the hippocampus and the orbitofrontal cortex are involved in inference-based behavior, according to a new study.

Scientists from Northwestern Medicine and the University of Belgrade have pinpointed the electrophysiological mechanism behind upper motor neuron disease, unlocking the door to potential treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

Neural signaling that encodes certain memories as negative could impact anxiety and substance misuse disorders, according to a recent study.

Sky Dominguez, a second-year student in the Medical Scientist Training Program, is currently studying the biological mechanisms underlying a sex difference in Alzheimer’s disease, as approximately two-thirds of those with the disease are women.

Northwestern Medicine investigators have discovered that eye movements are tightly linked to learning and retrieval, according to new findings.

The elevated expression of a gene called LY6K was correlated with increased cancer cell growth and resistance to radiation therapy in glioblastoma, according to a recent Northwestern Medicine study.

A new study reveals that dopamine regulates movement-promoting brain circuits more dynamically than previously envisaged.

Northwestern Medicine scientists have discovered that mutations in the largest genetic contributor to ALS leads to the dysfunction and eventual degeneration of certain specialized subtypes in the brain. The findings may lead to development of novel therapeutic interventions for the disease.

Northwestern Medicine scientists were able to significantly reduce brain swelling and damage after a traumatic brain injury by injecting nanoparticles into the bloodstream.

Northwestern Medicine scientists have recently discovered that two common genetic risk factors for Parkinson’s disease can be regulated with LRRK2 kinase inhibition or GCase enzyme activation, revealing potential for the development of new therapeutics.